Public Biotechs

topic on 1 show · 1 statements across 1 episodes

the a16z Podcast

1 statements about Public Biotechs, every show

a16z Assertion Supported

Nuzhna: One-fifth of public biotechs traded at or below cash balances

“Earlier this year we had something like one-fifths of public biotechs trading at or below their cash balances.”

Lada Nuzhna Nov 14, 2025 ▶ 1:44 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more